No, Memantine does not have abuse potential. On the contrary, it may prevent excess use of addictive drugs such as morphine or ethanol.

Dementia is a syndrome in which there is deterioration in memory, thinking, behavior, and the ability to perform everyday activities. Dementia is one of the major causes of disability and dependency among older people worldwide. Alzheimer disease is the most common form of dementia which contributes to around 60 to 70% of cases.

The symptoms which can be observed due to an overdose of Memantine include tiredness, weakness, drowsiness, confusion, hallucinations, and/or vomiting. Some may also experience diarrhea, vertigo, agitation, aggression, and walking difficulty.

Yes, Memantine can be combined with donepezil, as there will be no increased adverse effects. However, this combination will not cure Alzheimer's, but it can only improve thinking ability, short term memory, and other related symptoms.

Yes, Memantine may interfere with the working of hydrochlorothiazide (HCT). It decreases the levels of HCT which will reduce the effectiveness of HCT. Also, procainamide and quinidine may increase levels of Memantine which may cause increased toxicity.

Memantine belongs to a class of medications called N-methyl-D- aspartate (NMDA) receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember. It may also reduce the deterioration of these abilities in people who have Alzheimer's disease. However, with time the effectiveness of this medicine will reduce and it may not be able to cure Alzheimer's disease or prevent the loss of these abilities.

Memantine should be taken orally once a day. To benefit from your medicine you should take it regularly every day at the same time of the day. The tablets should be swallowed with some water. The tablets can be taken with or without food.

No, Memantine should not be stopped even if you feel well. This medicine only helps to control the symptoms of Alzheimer's disease but does not cure it. If you need to stop the medication then doctor should be consulted first.

Memantine belongs to a group of medicines called NMDA receptor antagonists. NMDA receptors are involved in the transmission of nerve signals within the brain such as in learning and memory. This medicine works by protecting NMDA receptors in the brain against high levels of the chemical glutamate, which could be the cause of brain degeneration. By doing so, Memantine may eventually improve your thinking capacity and your ability to remember.

For Memantine to start working and show its full benefits, it may require between 3 and 8 hours. The doctor may require a follow-up clinical assessment to check the progress after 4 weeks and then 6 months after the first assessment.

Yes, Memantine may make you sleepy. Memantine has minor to moderate influence on the ability to drive and usage of machines. In such cases, outpatients should be warned to take special care.